糖生物学市场份额报告| 2031 年规模、趋势和增长动力

Publication Month : Feb 2024

  • Report Code : TIPRE00037804
  • Category : Biotechnology
  • Status : Upcoming
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

[研究报告]糖生物学市场规模预计将从 2022 年的 15.1296 亿美元增长到 2030 年的 41.7893 亿美元;预计 2022 年至 2030 年市场复合年增长率为 13.56%。

市场洞察和分析师观点:

糖生物学是对广泛分布于自然界的糖类(也称为碳水化合物、糖链或聚糖)的结构、生物学、生物合成和进化的研究。性质和识别它们的蛋白质。糖生物学用于诊断、药物发现研究、免疫学、肿瘤学和其他应用。糖组仪器的技术进步是推动全球市场的重要因素之一。政府对研究的投资不断增加,以及制药和生物技术公司对新药开发的日益关注,进一步促进了糖生物学市场的扩张。此外,对糖生物学研究的日益关注也促进了市场的增长。例如,加州大学正在做出巨大努力来推进临床糖组学。 2021 年 9 月,加州大学圣地亚哥分校的研究人员开发了一种工具,允许使用人工智能和其他机器学习方法检查糖组学数据集。研究人员将该方法命名为 GlyCompare。它需要系统级的感知来解释样本内部和样本之间的聚糖的共享生物合成途径。通过这种方法,研究人员的目标是在癌症诊断方面取得临床突破。

战略见解

< /p>

增长动力:

增加糖组学研究并扩大研发;D 投资促进糖生物学市场增长

糖组学是对人体中发现的聚糖或糖结构的研究。这些聚糖可能非常复杂,存在于许多微生物组成分中,例如蛋白质和细胞表面。研究人员和市场参与者积极参与糖组学行业,并不断关注先进技术,为传统技术提供更好的替代方案。例如,

  • 2019 年 4 月,加拿大政府宣布在未来七年内提供 1000 万美元联邦资金,任命糖组学研究员 Lara Mahal 为加拿大阿尔伯塔大学卓越研究主席 (CERC)。
  • 2020 年 12 月,国家健康与医学研究委员会 (NHMRC) 向格里菲斯大学研究所提供了 266 万美元的 Ideas Grant 资金Glycomics 支持 4 个重要的糖组学研究项目。
  • 2021 年 6 月,新加坡科学技术研究局 (A*STAR) 运营的研究组织生物加工技术研究所 (BTI) ,和沃特世公司扩大了合作力度。为了确保生物制剂制造的整体安全性、准确性和效率,沃特世和 BTI 已开始开展一项新的联合项目:部署能够快速识别和显示糖组学和代谢组学数据中复杂化学物质的分析技术。
  • Genos 是世界顶级的高通量聚糖分析实验室,按照目前每年 30,000 多项研究的速度,它已经检查了超过 150,000 个不同的糖组。 Genos获得了2343万美元的非稀释性资助资金,其中1500万欧元用于十年来的IgG研究,发表了100多篇科学文章。 Genos 背后的研究团队正在使用系统生物学方法,将大量遗传、表观遗传、生化和生理数据与糖组数据整合起来。
  • 2022 年 3 月,日本研究人员发现了 β 的精确机制-1,2-葡聚糖相关酶,提供复杂糖代谢的新信息。新泻大学和东京理科大学的研究小组最近确定了一种具有糖基转移酶活性的新型酶的结构和功能。这项调查的结果于 2022 年 1 月 19 日公布,并刊登在《生物化学杂志》第 298 卷第 3 期上。
  • 根据研究人员 2022 年 2 月发表的一项研究在哥本哈根大学糖组学中心,现在可以通过糖组学研究在不使用动物的情况下生产肝素。
  • 2022 年 6 月,Thermo Fisher Scientific Inc. 和 TransMIT GmbH 质谱开发中心建立了一个联合营销合作伙伴关系,旨在促进质谱成像 (MSI) 技术在制药和临床实验室的空间多组学应用中的使用。该仪器可用于组学应用,例如各种组织的药代动力学研究、代谢组学、脂质组学、蛋白质组学和糖组学。

这些进步和不断增加的投资正在推动糖生物学市场显着。

报告细分和范围:

< span>“糖生物学市场”根据产品、应用程序和最终用户进行细分。根据产品,市场分为酶、试剂、试剂盒和仪器。酶片段又细分为糖苷酶、糖基转移酶、唾液酸转移酶、神经氨酸酶等。在应用方面,糖生物学市场分为药物发现和开发、诊断、免疫学、癌症等。根据最终用户,市场分为制药和生物技术公司、学术和研究机构以及合同研究组织。

细分分析:

根据产品,糖生物学市场分为酶、试剂、试剂盒、和仪器。 2022 年,酶细分市场占据了重要的市场份额,预计该细分市场将在 2022 年至 2030 年实现最快的复合年增长率。该产品领域增长的主要驱动因素是对药物发现和开发的需求不断增长、对相对高效仪器的日益偏好以及先进分析方法的日益采用,如高效液相色谱 (HPLC)、质谱 (MS)、和别的。酶片段又细分为糖苷酶、糖基转移酶、唾液酸转移酶、神经氨酸酶等。预计糖苷酶细分市场将在 2022 年占据最大份额,并且预计该细分市场在预测期内将以最高复合年增长率增长。酶领域增长的主要驱动因素是分子生物学、蛋白质工程和诊断学应用的开发以及生命科学行业研究活动的增加。

糖生物学市场,按产品分类 – 2022年和2030年

根据应用,糖生物学市场细分为药物发现以及开发、诊断、免疫学、癌症等。 2022年,药物发现和开发领域占据最大的市场份额。然而,诊断领域预计在 2022 年至 2030 年期间将以最高的复合年增长率增长。应用领域增长的主要驱动因素是孤儿和罕见疾病研究的增加、药物开发需求的增加以及对早期诊断的认识不断增强。传染病和罕见疾病的日益流行正在增加对最先进诊断系统的需求。技术进步使不同国家的医疗系统能够有效地诊断这些疾病。除了持续的研发活动和大量投资之外,对糖组学研究的试剂和试剂盒配方开发的日益关注也为快速可靠的诊断的推出做出了巨大贡献。聚糖分析通过提供释放和标记抗原和抗体糖型的有效方法来诊断传染病。此外,COVID-19 大流行导致对疾病检测的需求增加,以识别 SARS-CoV-2 的变种,因为该病毒在全球不同地理位置发生了显着突变。因此,导致诊断的传染病发病率的增加预计将推动该细分市场的增长。

根据最终用户,糖生物学市场分为制药和生物技术公司、学术机构以及研究机构和合同研究组织。 2022 年,制药和生物技术公司领域占据了很大的市场份额,预计该领域在 2022 年至 2030 年期间复合年增长率最快。最终用户市场增长的主要驱动因素是对各种健康疾病的新型治疗解决方案的需求不断增长以及市场整合的不断加强。对制药和生物技术产品需求的增长导致生物技术和制药公司之间进行大规模市场整合,以提供增强和更好的治疗选择。公司不断增长的投资促进了市场上制药和生物技术公司领域的发展。例如,2021年3月,安捷伦科技以高达6.95亿美元收购了基因组测序解决方案提供商Resolution Bioscience。此次收购旨在增强安捷伦在分子诊断市场的产品供应,包括基于液体活检的癌症检测。因此,公司为更好地利用机会来迎合客户而采取的无机策略预计将在预测期内促进该细分市场的增长。

区域分析:

根据地理位置,全球糖生物学市场分为亚太地区、欧洲、中东和非洲、北美、以及南美洲和中美洲。 2022年,北美在全球糖生物学市场中占据最大份额。预计亚太地区在 2022 年至 2030 年复合年增长率最高。

北美的糖生物学市场分为美国、加拿大和墨西哥。各部门不断增加的研究和合作活动、增加对糖组学研究的投资以及提高对糖组学的认识最终推动了预测期内的整个糖组学市场。

美国是最大的市场北美和世界糖生物学市场的贡献者。市场增长归因于各机构和部门研究活动的增加以及糖组学研究投资的增加。此外,不断增加的研究投资举措是糖生物学市场增长的另一个因素。例如,2022 年 2 月,美国国家科学基金会 (NSF) 向弗吉尼亚理工大学和佐治亚大学 2020 年联合管理的新的多大学合作伙伴关系拨款近 2300 万美元,以加速美国的糖材料研究。此次合作汇聚了来自这些机构以及布兰代斯大学、伦斯勒理工学院和北卡罗来纳大学教堂山分校的顶尖科学家和工程师,建立了国家岩土材料研究中心。

美国的支持性环境加速了糖组学药物和生物制药产品的开发和商业化的增长。因此,制药和生物制药行业的增长对区域市场做出了重大贡献,这将推动 Glycomics 市场的增长和机遇。

行业发展和未来机遇:

糖生物学市场领先企业采取的各种举措如下:

< ol>
  • 2022 年 3 月,创新蛋白质组学和糖生物学解决方案的先驱 Vector Laboratories 在加利福尼亚州纽瓦克开设了新工厂。这些免疫荧光 (IF) 试剂盒能够对生物系统中的复杂聚糖进行分析和表征,并且完全集成用于检测组织切片中的聚糖表达。
  • 2022 年 6 月,赛默飞世尔科技 (Thermo Fisher Scientific) 宣布与 TransMIT GmbH 质谱开发中心达成联合营销协议,鼓励在制药和制药行业使用质谱成像平台进行空间多组学应用。
  • 2022 年 4 月,布鲁克利用 AmberGen 的 HiPLEX-IHC 肽码抗体探针,结合公正的脂质组学、糖组学和代谢组学,推出了适用于 timsTOF flex 的新型 MALDI HiPLEX-IHC 组织成像解决方案
  • 2022 年 1 月,安捷伦科技投资 2000 万美元扩建上海制造中心,以满足中国对公司先进液相色谱 (LC)、光谱仪、和质谱 (MS) 系统。

    竞争格局和主要公司:

    Merck KGaA、Agilent Technologies, Inc.、New England Biolabs、Thermo Fisher Scientific Inc.、Waters Corporation、Asparia Glycomics、Bruker Corporation、Takara Bio Inc.、S-BIO 和 Shimadzu Corporation 是著名的糖生物学领域市场公司。这些公司专注于新技术、现有产品的进步和地域扩张,以满足全球不断增长的消费者需求。

  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    • Merck KGaA
    • Agilent Technologies, Inc.
    • New England Biolabs
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
    • Asparia Glycomics
    • Bruker Corporation
    • Takara Bio Inc.
    • S-BIO
    • Shimadzu Corporation

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports